Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

(2021) Michael J. Joyner et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Vaccines

(2021) C. Buddy Creech et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020

(2021) Isabelle Sermet-Gaudelus et al.   Eurosurveillance

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

(2021) Stefania Dispinseri et al.   Nature Communications

A ‘mix and match’ approach to SARS-CoV-2 vaccination

(2021) Meagan E. Deming et al.   NATURE MEDICINE

On the mechanism of anti-CD39 immune checkpoint therapy

(2020) David Allard et al.   Journal for ImmunoTherapy of Cancer

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

A serological assay to detect SARS-CoV-2 seroconversion in humans

(2020) Fatima Amanat et al.   NATURE MEDICINE

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2020) Xiuyuan Ou et al.   Nature Communications

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

(2020) Xiaoli Wang et al.   CLINICAL INFECTIOUS DISEASES

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

(2020) Julian Braun et al.   NATURE

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

(2020) Nina Le Bert et al.   NATURE

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

(2020) Chee Wah Tan et al.   NATURE BIOTECHNOLOGY

Broad neutralization of SARS-related viruses by human monoclonal antibodies

(2020) Anna Z. Wec et al.   SCIENCE

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

(2020) Jose Mateus et al.   SCIENCE

High Frequency of Shared Clonotypes in Human T Cell Receptor Repertoires

(2020) Cinque Soto et al.   Cell Reports

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

(2020) Takuya Sekine et al.   CELL

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

(2020) Yanchun Peng et al.   NATURE IMMUNOLOGY

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes

(2020) Tal Noy-Porat et al.   Nature Communications

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

(2020) Fan Wu et al.   JAMA Internal Medicine

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells

(2019) Catherine Rabu et al.   OncoImmunology

Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in highly public receptors

(2019) Nathaniel D. Chu et al.   BMC IMMUNOLOGY

Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines

(2019) Sanjay G. Patel et al.   Scientific Reports

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display

(2019) Stina L. Wickström et al.   Frontiers in Immunology

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines

(2018) Brett J. Hos et al.   Frontiers in Immunology

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany

(2018) Raskit Lachmann et al.   PLoS One

Origin and evolution of pathogenic coronaviruses

(2018) Jie Cui et al.   NATURE REVIEWS MICROBIOLOGY

Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore

(2018) Christoph Allolio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

(2016) Qidi Wang et al.   ACS Infectious Diseases

DockTope: a Web-based tool for automated pMHC-I modelling

(2015) Maurício Menegatti Rigo et al.   Scientific Reports

T-cell receptor repertoires share a restricted set of public and abundant CDR3 sequences that are associated with self-related immunity

(2014) Asaf Madi et al.   GENOME RESEARCH

Long Synthetic Peptides for the Production of Vaccines and Drugs: A Technological Platform Coming of Age

(2010) G. Corradin et al.   Science Translational Medicine

The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length

(2009) Melissa J. Bell et al.   MOLECULAR IMMUNOLOGY

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

(2008) Anna Lissina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11

(2008) Claus Lundegaard et al.   NUCLEIC ACIDS RESEARCH